Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1252, 2000-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is Omapatrilat a Novel Therapy of the Past Rather Than the Future?
By Cheng T.O.
Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. :
Access to resources
Recommend
Candesartan cilexetil + lisinopril superior to monotherapies?
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :
Validity of Cost and Utility Results?
PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. :
Another Year Over, So What Lies Ahead?
Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 12, 2005-01 ,pp. :
-Blockers' reign in primary hypertension over?
Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. :